−0.1041 USD
−1.50 M USD
13.22 M USD
16.80 M
About CRESCITA THERAPEUTICS INC
Sector
CEO
Serge Verreault
Headquarters
Laval
Website
Founded
2016
FIGI
BBG00CNHY6R0
Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. Its products include Pliaglis, Alyria, Laboratoire Dr Renaud, and Pro-Derm. It operates through the following business segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells non-prescription skincare products. The Licensing and Royalties segment refers to the licensing related to its prescription product. The Manufacturing and Services segment relates to the sale of topical products and product development services. The company was founded on March 1, 2016 and is headquartered in Laval, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CRRTF is 0.4490 USD — it has increased by 3.62% in the past 24 hours. Watch Crescita Therapeutics Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Crescita Therapeutics Inc stocks are traded under the ticker CRRTF.
CRRTF reached its all-time high on Sep 8, 2016 with the price of 1.4511 USD, and its all-time low was 0.0210 USD and was reached on Aug 15, 2024. View more price dynamics on CRRTF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CRRTF stock is 3.50% volatile and has beta coefficient of −0.03. Track Crescita Therapeutics Inc stock price on the chart and check out the list of the most volatile stocks — is Crescita Therapeutics Inc there?
Today Crescita Therapeutics Inc has the market capitalization of 8.16 M, it has decreased by −4.34% over the last week.
Yes, you can track Crescita Therapeutics Inc financials in yearly and quarterly reports right on TradingView.
CRRTF net income for the last quarter is −765.65 K USD, while the quarter before that showed −676.63 K USD of net income which accounts for −13.16% change. Track more Crescita Therapeutics Inc financial stats to get the full picture.
No, CRRTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 80.00 employees. See our rating of the largest employees — is Crescita Therapeutics Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Crescita Therapeutics Inc EBITDA is −1.24 M USD, and current EBITDA margin is −2.57%. See more stats in Crescita Therapeutics Inc financial statements.
Like other stocks, CRRTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Crescita Therapeutics Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Crescita Therapeutics Inc technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Crescita Therapeutics Inc stock shows the buy signal. See more of Crescita Therapeutics Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.